320 related articles for article (PubMed ID: 3092053)
1. Withdrawal reaction after long-term therapeutic use of benzodiazepines.
Busto U; Sellers EM; Naranjo CA; Cappell H; Sanchez-Craig M; Sykora K
N Engl J Med; 1986 Oct; 315(14):854-9. PubMed ID: 3092053
[TBL] [Abstract][Full Text] [Related]
2. The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.
Mercier-Guyon C; Chabannes JP; Saviuc P
Curr Med Res Opin; 2004 Sep; 20(9):1347-55. PubMed ID: 15383182
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
Lemoine P; Touchon J; Billardon M
Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
[TBL] [Abstract][Full Text] [Related]
4. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study.
Gerra G; Zaimovic A; Giusti F; Moi G; Brewer C
Addict Biol; 2002 Oct; 7(4):385-95. PubMed ID: 14578014
[TBL] [Abstract][Full Text] [Related]
5. Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.
Busto UE; Naranjo CA; Bremner KE; Peachey JE; Bologa M
J Psychiatry Neurosci; 1998 Jan; 23(1):35-44. PubMed ID: 9505058
[TBL] [Abstract][Full Text] [Related]
6. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
[TBL] [Abstract][Full Text] [Related]
7. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
[TBL] [Abstract][Full Text] [Related]
8. [alpha-beta L-aspartate magnesium in treatment of chronic benzodiazepine abuse: controlled and double-blind study versus placebo].
Hantouche EG; Guelfi JD; Comet D
Encephale; 1998; 24(5):469-79. PubMed ID: 9850822
[TBL] [Abstract][Full Text] [Related]
9. Protracted tinnitus after discontinuation of long-term therapeutic use of benzodiazepines.
Busto U; Fornazzari L; Naranjo CA
J Clin Psychopharmacol; 1988 Oct; 8(5):359-62. PubMed ID: 2903182
[TBL] [Abstract][Full Text] [Related]
10. A clinical scale to assess benzodiazepine withdrawal.
Busto UE; Sykora K; Sellers EM
J Clin Psychopharmacol; 1989 Dec; 9(6):412-6. PubMed ID: 2574193
[TBL] [Abstract][Full Text] [Related]
11. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
[TBL] [Abstract][Full Text] [Related]
12. Double-blind placebo cross-over study of long-acting (chlordesmethyldiazepam) versus short-acting (lorazepam) benzodiazepines in generalized anxiety disorders.
Bertin I; Colombo G; Furlanut M; Benetello P
Int J Clin Pharmacol Res; 1989; 9(3):203-8. PubMed ID: 2568350
[TBL] [Abstract][Full Text] [Related]
13. Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.
Cohn JB
J Clin Psychiatry; 1981 Sep; 42(9):347-51. PubMed ID: 6115853
[TBL] [Abstract][Full Text] [Related]
14. A programme for short-term withdrawal from benzodiazepines in geriatric hospital inpatients: success rate and effect on subjective sleep quality.
Petrovic M; Pevernagie D; Van Den Noortgate N; Mariman A; Michielsen W; Afschrift M
Int J Geriatr Psychiatry; 1999 Sep; 14(9):754-60. PubMed ID: 10479747
[TBL] [Abstract][Full Text] [Related]
15. A comparison of buspirone and placebo in relieving benzodiazepine withdrawal symptoms.
Lader M; Olajide D
J Clin Psychopharmacol; 1987 Feb; 7(1):11-5. PubMed ID: 2880872
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
Small GW; Bystritsky A
J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
[TBL] [Abstract][Full Text] [Related]
17. A double-blind comparison of the efficacy and safety of lorazepam and diazepam in the treatment of the acute alcohol withdrawal syndrome.
Miller WC; McCurdy L
Clin Ther; 1984; 6(3):364-71. PubMed ID: 6722863
[TBL] [Abstract][Full Text] [Related]
18. Alprazolam compared to diazepam and placebo in the treatment of anxiety.
Aden GC; Thein SG
J Clin Psychiatry; 1980 Jul; 41(7):245-8. PubMed ID: 6993446
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome.
Lemoine P; Kermadi I; Garcia-Acosta S; Garay RP; Dib M
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):131-7. PubMed ID: 16243418
[TBL] [Abstract][Full Text] [Related]
20. In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods.
McGregor C; Machin A; White JM
Drug Alcohol Rev; 2003 Jun; 22(2):175-80. PubMed ID: 12850904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
